ArticleIJU case reports2024
Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinoma.
Kazuki Yanagida et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it